European AIDS Treatment Group·2 min read·medium

[AIDS 2026] aidsmap: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)

H
https://www.facebook.com/EuropeanAIDSTreatmentGroup
[AIDS 2026] aidsmap: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)
AI Summary

The AIDS 2026 conference highlighted a renewed scientific interest in post-exposure prophylaxis (PEP) for HIV. Current guidelines emphasize starting the four-week treatment course within 72 hours of potential exposure.

An unexpected but welcome development at AIDS 2026 was the reappearance of post-exposure prophylaxis (PEP) for HIV as a subject for scientific study and funding.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

[AIDS 2026] aidsmap: Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP) — Headlinne — headlinne